Haemonetics (HAE) Tops Q3 EPS by 18c, Revenues Beat; Raises FY20 EPS Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 116.40 +0.24 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.16 | 52 Week High | $39.41 | |||
| Open | $115.50 | 52 Week Low | $25.98 | |||
| Day High | $117.52 | P/E | 163.94 | |||
| Day Low | $115.49 | EPS | $0.71 | |||
| Volume | 181,424 | |||||
